Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.
作者信息
Jain Preetesh, Kantarjian Hagop, Jain Nitin, Short Nicholas J, Yin Cameron C, Kanagal-Shamanna Rashmi, Khoury Joseph, Konopleva Marina, Sasaki Koji, Kadia Tapan M, Garris Rebecca, Pierce Sherry, Estrov Zeev, Wierda William, Cortes Jorge, O'Brien Susan, Ravandi Farhad, Jabbour Elias
机构信息
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
出版信息
Am J Hematol. 2017 Oct;92(10):E595-E597. doi: 10.1002/ajh.24833. Epub 2017 Jul 29.
Abstract
摘要
相似文献
1
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.采用基于高剂量环磷酰胺、长春新碱、阿霉素和地塞米松（Hyper-CVAD）方案治疗的初治成人T细胞急性淋巴细胞白血病和T淋巴母细胞淋巴瘤患者的临床特征及预后
Am J Hematol. 2017 Oct;92(10):E595-E597. doi: 10.1002/ajh.24833. Epub 2017 Jul 29.
2
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.成人T细胞急性淋巴细胞白血病和T淋巴母细胞淋巴瘤采用hyper-CVAD联合奈拉滨作为一线治疗方案：MD安德森癌症中心的经验
Leukemia. 2014 Apr;28(4):973-5. doi: 10.1038/leu.2013.312. Epub 2013 Oct 25.
3
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. Venetoclax 联合化疗治疗复发或难治性 T 细胞急性淋巴细胞白血病的临床经验。
Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):212-218. doi: 10.1016/j.clml.2019.09.608. Epub 2019 Sep 30.
4
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.T 细胞急性淋巴细胞白血病/淋巴瘤的转归：关注近 T 淋母细胞表型和那拉滨的差异影响。
Am J Hematol. 2021 May 1;96(5):589-598. doi: 10.1002/ajh.26144. Epub 2021 Mar 18.
5
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.高剂量环磷酰胺、长春新碱、阿霉素及地塞米松（Hyper-CVAD）方案，一种剂量密集型方案，用于成人急性淋巴细胞白血病的长期随访结果。
Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668.
6
Hyper-CVAD regimen in routine management of adult acute lymphoblastic leukemia: a retrospective multicenter study.常规治疗成人急性淋巴细胞白血病的 Hyper-CVAD 方案：一项回顾性多中心研究。
Acta Haematol. 2013;130(3):199-205. doi: 10.1159/000351172. Epub 2013 Jun 19.
7
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers.BFM方案治疗成人急性淋巴细胞白血病是否可行？两个中心BFM与Hyper-CVAD化疗结局的回顾性分析
Chemotherapy. 2014;60(4):219-23. doi: 10.1159/000375258. Epub 2015 Apr 3.
8
Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD.
Hematology. 2018 Mar;23(2):83-88. doi: 10.1080/10245332.2017.1355421. Epub 2017 Aug 4.
9
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.对于接受基于大剂量环磷酰胺、长春新碱、阿霉素和地塞米松（hyper-CVAD）一线方案治疗的成年急性淋巴细胞白血病患者，TP53突变并不会导致不良预后。
Cancer. 2017 Oct 1;123(19):3717-3724. doi: 10.1002/cncr.30810. Epub 2017 Jun 13.
10
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.采用强化环磷酰胺、长春新碱、多柔比星及地塞米松（hyper-CVAD）联合利妥昔单抗进行化学免疫治疗，用于治疗成人伯基特淋巴瘤和伯基特样淋巴瘤或急性淋巴细胞白血病。
Cancer. 2006 Apr 1;106(7):1569-80. doi: 10.1002/cncr.21776.
引用本文的文献
1
Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.县级医院系统中初诊急性淋巴细胞白血病患者的临床结局。
Clin Lymphoma Myeloma Leuk. 2021 Nov;21(11):e895-e902. doi: 10.1016/j.clml.2021.06.022. Epub 2021 Jul 4.
2
Orbital precursor B-lymphoblastic lymphoma involving the extraocular muscles in a 56-year-old male and a review of the literature.一名56岁男性眼眶前体B淋巴细胞淋巴瘤累及眼外肌并文献复习
Oncol Lett. 2019 Feb;17(2):1477-1482. doi: 10.3892/ol.2018.9725. Epub 2018 Nov 19.
本文引用的文献
1
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.成人T细胞急性淋巴细胞白血病和T淋巴母细胞淋巴瘤采用hyper-CVAD联合奈拉滨作为一线治疗方案：MD安德森癌症中心的经验
Leukemia. 2014 Apr;28(4):973-5. doi: 10.1038/leu.2013.312. Epub 2013 Oct 25.
2
T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.T 细胞淋巴母细胞淋巴瘤通过基因组和基因表达分析显示出与 T 细胞急性淋巴细胞白血病的差异和相似之处。
Genes Chromosomes Cancer. 2011 Dec;50(12):1063-75. doi: 10.1002/gcc.20924. Epub 2011 Aug 30.
3
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).成人 T 细胞急性淋巴细胞白血病：来自大型随机前瞻性试验（UKALL XII/ECOG 2993）的临床特征、免疫表型、细胞遗传学和结果。
Blood. 2009 Dec 10;114(25):5136-45. doi: 10.1182/blood-2009-08-231217.
4
T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?T细胞淋巴母细胞淋巴瘤与T细胞急性淋巴细胞白血病：是独立的实体吗？
Clin Lymphoma Myeloma. 2009;9 Suppl 3:S214-21. doi: 10.3816/CLM.2009.s.015.
5
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL).LMT - 89方案在淋巴细胞淋巴瘤（LL）中生存率高，但在T细胞急性淋巴细胞白血病（T - ALL）中并非如此。
Leukemia. 2006 May;20(5):814-9. doi: 10.1038/sj.leu.2404156.
6
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.成人急性淋巴细胞白血病的诱导治疗：来自国际ALL试验（MRC UKALL XII/ECOG E2993）1500多名患者的结果。
Blood. 2005 Dec 1;106(12):3760-7. doi: 10.1182/blood-2005-04-1623. Epub 2005 Aug 16.
7
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.淋巴细胞淋巴瘤采用高剂量环磷酰胺、长春新碱、多柔比星和地塞米松（hyper-CVAD）方案的治疗结果。
Blood. 2004 Sep 15;104(6):1624-30. doi: 10.1182/blood-2003-12-4428. Epub 2004 Jun 3.
8
Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia.按照急性淋巴细胞白血病方案治疗的成年T淋巴细胞母细胞淋巴瘤患者的结局
Blood. 2002 Jun 15;99(12):4379-85. doi: 10.1182/blood-2002-01-0110.
Zotero 插件